Literature DB >> 7127910

Asbestos related changes in pulmonary and systemic immune responses--early enhancement followed by inhibition.

M Rola-Pleszczynski, I Lemaire, P Sirois, S Massé, R Bégin.   

Abstract

We recently developed an animal model in order to study the pulmonary and systemic reactions following exposure to environmental pollutants. In this model, conscious sheep received repeated intratracheal instillations of a suspension of 0 (controls), 2mg (low dose) or 128 mg (high dose) of chrysotile asbestos fibres over a 12 month period. A significant dose-dependent enhancement in proliferative responses of pulmonary free airway cells (FAC) to four mitogens was observed after a first instillation. A somewhat weaker stimulation was also observed in peripheral blood mononuclear leucocytes (PBML). At 6 months, the high dose animals no longer displayed the dose-dependent enhancement of FAC responses and manifested actual depression of PBML responses. At 12 months, all asbestos exposed animals showed impaired responses of FAC, whereas only the PBML of high dose animals were showing such an impairment. These data suggest that asbestos exposure has a dose-dependent initial enhancement of local pulmonary as well as systemic responses to mitogens while prolonged exposure and higher doses can subsequently lead to a relative depression of local and systemic cellular immune activity. Although responsive early after asbestos exposure, systemic immunity appears to lag behind local immunity in the late depressive effect of asbestos fibres on mitogen responsiveness. In addition to these cell-directed effects serum factors seem to play an inhibitory role in lymphocyte responses to mitogens in animals repeatedly exposed to asbestos.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7127910      PMCID: PMC1536495     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Immunological studies of patients with asbestosis. I. Studies of cell-mediated immunity.

Authors:  E Kagan; A Solomon; J C Cochrane; E I Beissner; J Gluckman; P H Rocks; I Webster
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

Review 2.  Asbestos-related diseases of the lung and other organs: their epidemiology and implications for clinical practice.

Authors:  M R Becklake
Journal:  Am Rev Respir Dis       Date:  1976-07

Review 3.  The effects of asbestos on macrophages.

Authors:  K Miller
Journal:  CRC Crit Rev Toxicol       Date:  1978-09

4.  Purification of human monocytes by continuous gradient sedimentation in ficoll.

Authors:  M Rola-Pleszczynski; W H Churchill
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

5.  Immunological studies of patients with asbestosis. II, Studies of circulating lymphoid cell numbers and humoral immunity.

Authors:  E Kagan; A Solomon; J C Cochrane; P Kuba; P H Rocks; I Webster
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

6.  Monocyte enhancement of mitogen-induced lymphocyte proliferation in a human co-culture system.

Authors:  J R Hollister; C E Jarrett
Journal:  Cell Immunol       Date:  1978-12       Impact factor: 4.868

7.  Asbestos exposure as a cause of immunological stimulation.

Authors:  M S Huuskonen; J A Räsänen; H Härkönen; S Asp
Journal:  Scand J Respir Dis       Date:  1978

8.  Cellular immunity in asbestosis.

Authors:  A Lange; R Smolik; W Chmielarczyk; D Garncarek; Z Gielgier
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1978       Impact factor: 4.291

9.  Subpopulations of human T cells identified by receptors for immunoglobulins and mitogen responsiveness.

Authors:  L Moretta; M Ferrarini; M C Mingari; A Moretta; S R Webb
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

10.  Lymphocyte responses to phytohaemagglutinin in patients with asbestosis and pleural mesothelioma.

Authors:  P L Haslam; A Lukoszek; J A Merchant; M Turner-Warwick
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

View more
  4 in total

1.  High frequency of immune dysfunctions in asbestos workers and in patients with malignant mesothelioma.

Authors:  F Lew; P Tsang; J F Holland; N Warner; I J Selikoff; J G Bekesi
Journal:  J Clin Immunol       Date:  1986-05       Impact factor: 8.317

2.  Pulmonary and systemic immunoregulatory changes during the development of experimental asbestosis.

Authors:  M Rola-Pleszczynski; S Gouin; R Bégin
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

3.  Environmental silica in badger lungs: a possible association with susceptibility to Mycobacterium bovis infection.

Authors:  D A Higgins; I T Kung; R S Or
Journal:  Infect Immun       Date:  1985-04       Impact factor: 3.441

4.  Asbestos-induced lung inflammation. Role of local macrophage-derived chemotactic factors in accumulation of neutrophils in the lungs.

Authors:  M Rola-Pleszczynski; S Gouin; R Bégin
Journal:  Inflammation       Date:  1984-03       Impact factor: 4.092

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.